Carrier Screening Market - By Test Type: Targeted Carrier Screening, Expanded Carrier Screening; By Technology: DNA Sequencing (NGS), Polymerase Chain Reaction (PCR), Microarrays; By End User: Hospitals, Clinical Laboratories, IVF Centers, Specialty Clinics; By Region: North America, Europe, Asia-Pacific Latin America and Others
1 | Market Overview
The global carrier screening market is experiencing rapid growth due to increased demand for genetic testing, greater awareness of inherited disorders, and advances in next-generation sequencing (NGS) technologies. Carrier screening is conducted to identify if an individual carries a gene for specific genetic conditions that could be passed on to their children.
Growing focus on reproductive health, government support for genetic counseling, and a surge in IVF and preimplantation genetic diagnosis are driving increased demand. Advances in expanded carrier screening panels now enable simultaneous testing for hundreds of conditions, improving accessibility and accuracy.
2 | Market Size and Forecast
|
Year |
Market Value (USD Billion) |
Notes |
|
2019 |
1.32 |
Historical benchmark |
|
2024 |
2.15 |
Five-year CAGR 10.2% |
|
2031 |
4.87 |
Seven-year CAGR 12.1% |
The market is projected to more than double by 2031, driven by expanded reproductive genetics services and declining sequencing costs.
3 | Key Market Drivers
4 | Market Challenges
5 | Competitive Landscape
The market is moderately consolidated with key genomics and diagnostics companies leading globally, supported by laboratory service providers and health tech startups.
Market Share Estimates (2024):
|
Company |
Estimated Market Share |
Key Offerings |
|
Invitae Corporation |
22% |
Comprehensive carrier screening panels |
|
Natera Inc. |
18% |
Horizon™ Carrier Screening |
|
Myriad Genetics |
17% |
Foresight® Carrier Screen |
|
Fulgent Genetics |
11% |
Expanded panel testing |
|
Others (Quest, Labcorp, Sema4, GeneDx) |
32% |
Laboratory networks and regional providers |
6 | Market Segmentation
By Test Type:
By Technology:
By End User:
By Region:
7 | Strategic Outlook
Integration with digital health platforms, AI-driven variant interpretation, and consumer-centric genetic services will fuel future growth. Partnerships between labs, fertility clinics, and telehealth providers will accelerate access
Need help?
Chat with our team in a minute.